MASP-2 and MASP-3 inhibitors, and related compositions and methods, for treatment of sickle cell disease.
OA22318AActive Publication Date: 2026-09-30OMEROS CORP +1
0 Cites 0 Cited by
Patent Information
- Application Number
- OA1202500347
- Authority / Receiving Office
- OA · OA
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-03-09
- Publication Date
- 2026-09-30
- Estimated Expiration
- 2043-03-09
Abstract
The present disclosure relates to the use of MASP-2 inhibitors and / or MASP-3 inhibitors and compositions comprising the same for treatment of sickle cell disease, including treatment, reduction, and / or prevention of sickle cell disease symptoms or manifestations.
Need to check novelty before this filing date? Find Prior Art